Biological synthesis using recombinant production systems has been described as the most cost-effective procedure for large-scale production of peptides (Li, 2011). These processes have been simplified in recent decades by the development of a large number of cloning vectors, host strains, fusion proteins and different tags, tools that altogether greatly simplify the isolation of recombinant AMPs from microbial cultures.